Home FDLI Food and Drug Law Institute

Join us for a two-day conference on September 10-11 in São Paulo, Brazil where government officials and internationally renowned experts will discuss US and Brazil pharmaceutical, medical device, and food law, regulation, and policy.more

This joint conference presented by the American Health Lawyers Association and the Food and Drug Law Institute will address three significant areas of intersection: Reimbursement, fraud and abuse, and research/clinical trial issues. more

Save the Date: April 23-24, 2013more

SPECIAL OFFER AVAILABLE NOW. Save $250 on the Online Version, and $100 on the Print. FDLI's FDA directory, theLINK, is a comprehensive directory of FDA employees and select employees of other agencies including USDA, FTC, CMS, CDC and AHRQ.more

Save the date for FDLI's annual #advertising and promotion conference - ... Posted 10 hrs ago

WHO WE ARE

The Food and Drug Law Institute, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. The scope of FDLI includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco. FDLI is a not-for-profit 501(c)(3) organization. FDLI does not engage in advocacy activities.

FDLI’s Mission is to provide education, training, and publications on topical food and drug law; act as a liaison to promote networking as a means to develop professional relationships and idea generation; and ensure an open, balanced marketplace of ideas to inform innovative public policy, law, and regulation.

Publications
Upcoming Events
Featured

Members Only Content Food Safety at the Crossroads: How FSMA Is Changing the Landscape with Khara Minter, Foods Team Member
March 2012 (Update Article)

"Pink Slime" Discussed in Latest Food and Drug Policy Forum with Richard L. Frank and Robert A. Hahn
May 2012 (Policy Forum)

Accounting for Heterogeneous Treatment Effects in the FDA Approval Proce... with Anup Malani, Oliver Bembom and Mark van der Laan
March 2012 (Journal Article)

Top 20 Food and Drug Cases, 2011 & Cases to Watch, 2012 with John B. Reiss and Gregory J. Wartman, Editors
April 2012 (Book)

Members Only Content Controlled Substance Regulation and Enforcement: Understanding FDA and D... with FDLI
March 2012 (Update Article)

Should Congress Expand FDA Authority Over Cosmetics and, if so, How? with Thomas Cluderay and Jason Rano
April 2012 (Policy Forum)

The Intersecting Worlds of Drug, Device, Biologics, and Health Law with FDLI
May 2012

Introduction to Medical Device Law and Regulation: The Legal Framework f... with FDLI
June 2012

Medical Device Regulation and Litigation Conference with FDLI
June 2012

Regenerative Medicine: Key Developments in Regulation & Commercialization with FDLI
June 2012

IP Throughout the Drug Development Lifecycle: Opportunities and Challenges with FDLI
July 2012

Top 20 Food and Drug Cases, 2011 & Cases to Watch, 2012 with John B. Reiss and Gregory J. Wartman, Editors
April 2012 (Book)

Food and Drug Law and Regulation, 2nd Edition with David G. Adams, Richard M. Cooper, Martin J. Hahn & Jonathan S. Kahan, Editors
December 2011 (Book)

FDCA Statutory Supplement 2011, Second Edition with Joy J. Liu, Esq.
June 2011 (Book)

Compilation of Selected Chinese State Food and Drug Administration (SFDA... with Wang Chenguang and Gordon B. Schatz, Editors
June 2011 (Book)

FDLI

WHO WE ARE

RESOURCES

Latest News from SmartBrief